home / stock / elev / elev news


ELEV News and Press, Elevation Oncology Inc. From 02/28/24

Stock Information

Company Name: Elevation Oncology Inc.
Stock Symbol: ELEV
Market: NASDAQ
Website: elevationoncology.com

Menu

ELEV ELEV Quote ELEV Short ELEV News ELEV Articles ELEV Message Board
Get ELEV Alerts

News, Short Squeeze, Breakout and More Instantly...

ELEV - Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology to Participate in Upcoming Investor Conferences PR Newswire BOSTON , Feb. 28, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to...

ELEV - 3 Stock Winners That Are Up 400% or More in 2024

2024-02-23 09:17:55 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market has seen a remarkable surge in recent months, climbing 21% since the end of October. Rallies as strong as this one tend to yield several stock winners, which in this case are p...

ELEV - Annovis Bio, Kura Oncology among other healthcare movers

2024-01-24 10:01:06 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

ELEV - Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors PR Newswire BOSTON , Jan. 22, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of select...

ELEV - Elevation Oncology: Rising On News, But Not The Time To Buy

2024-01-17 15:21:00 ET Summary Elevation Oncology experienced a significant increase in market capitalization in early 2024 based on positive guidance, but the company's main program is still early and risky. The company is focused on developing EO-3021, a novel antibody-drug conj...

ELEV - Catalyst Watch: Eyes on oil, Goldman Sachs earnings, Samsung event and Oddity Tech lockup expiration

2024-01-12 15:00:30 ET More on the markets S&P 500: Traders Buy, Investors Sell Recession Forecasting - The Business Cycle Back To 1928 (Part 2) 2024 Analyst Outlook: Victor Dergunov On Undervalued Sectors Uncovering New Year Opportunities Investors were ...

ELEV - YMAB, ELEV and CRGE among mid-day movers

2024-01-12 13:03:06 ET Gainers: Charge Enterprises ( CRGE ) +187% . SYLA Technologies Co Ltd ( SYT ) +71% . ProMIS Neurosciences PMN +30% . Y-Mabs Therapeutics ( YMAB ) +30% . Applied UV AUVI +30% . Volcon VLCN +31% . Elevati...

ELEV - EKSO, SATS and UK among mid-day movers

2024-01-10 12:47:50 ET Gainers: Sana Biotechnology SANA +44% . Clearmind Medicine CMND +43% . EchoStar Corp ( SATS ) +37% . SEALSQ Corp LAES +31% . Ucommune International Ltd ( UK ) +27% . iCoreConnect ICCT +24% . Elevation Oncol...

ELEV - Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

2024-01-09 10:25:55 ET Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 9...

ELEV - Elevation Oncology says its cash, cash equivalents sufficient to fund operations into 2H25

2024-01-05 13:23:34 ET More on Elevation Oncology Seeking Alpha’s Quant Rating on Elevation Oncology Historical earnings data for Elevation Oncology Financial information for Elevation Oncology For further details see: Elevation Oncology says its c...

Previous 10 Next 10